ANA ISABEL
MUÑAGORRI SANTOS
Forscherin bis um 2022
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario Nuestra Señora de Candelaria (2)
2022
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15